SAUDI VISION 2030

The Vanderbilt Terminal for Saudi Arabia's National Transformation

INDEPENDENT GLOBAL INTELLIGENCE FOR THE KINGDOM OF SAUDI ARABIA

Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target | Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target |

SFDA

All Articles

programmatic

Saudi Pharmaceutical Manufacturing

A detailed examination of Saudi Arabia's pharmaceutical manufacturing sector, covering localisation targets, key producers, regulatory developments, and the strategic alignment with Vision 2030's healthcare and [industrial diversification](/sectors/) objectives.

Feb 22, 2026